Search clinical trials for: PHY606

Total 6 results

Sheng-Teng Huang

Completed

Development of PHY606 as Adjunct Therapy for Anemia Patients

Anemia | Herbal Interaction

Taiwan
PhytoCeutica

Terminated

Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer

Diarrhea | Colorectal Neoplasms

United States
Eyevensys

Completed

Evaluation of EYS606 in Patients With Non-infectious Posterior, Intermediate or Panuveitis

Non-infectious Uveitis

France, United Kingdom
PhytoCeutica

Completed

Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma | Liver Cancer

United States, Taiwan
Yale University
Roche Pharma AG; National Comprehensive Cancer Network; PhytoCeutica

Completed

A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma

Pancreatic Cancer

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer

Advanced Adult Hepatocellular Carcinoma | Advanced Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma | BCLC Stage B Adult Hepatocellular Carcinoma | BCLC Stage C Adult Hepatocellular Carcinoma

United States

3

Subscribe